Prognostic significance of tumour Ki-67 dynamics during neoadjuvant treatment in patients with breast cancer: a population-based cohort studyResearch in context

Summary: Background: Although Ki-67 is a commonly used proliferation marker in breast cancer (BC), its prognostic value after neoadjuvant chemotherapy (NACT) remains unclear. This study aims to investigate the prognostic implications of Ki-67 dynamics during NACT. Methods: Patients with invasive BC...

Full description

Bibliographic Details

Published in:	The Lancet Regional Health. Europe
Main Authors:	Maria Angeliki Toli, Xingrong Liu, Davide Massa, Stefania Lando, Caroline Boman, Nikolaos Tsiknakis, Christian Tranchell, Andri Papakonstantinou, Giuseppe Fotia, Claudio Vernieri, Valentina Guarneri, Jonas Bergh, Maria Vittoria Dieci, Louise Eriksson Bergman, Alexios Matikas, Theodoros Foukakis
Format:	Article
Language:	English
Published:	Elsevier 2025-11-01
Subjects:	Breast cancer Neoadjuvant chemotherapy Ki-67 Prognosis Survival Stratification
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666776225002248